1. Human Life CORD

https://www.humanlifecord.com/

· Year Founded: 2017

· Total Raised to Date: $13.1M

· Overview:

Human Life CORD is a company engaged in the research, development, manufacture and sale of regenerative medical products and medical devices.

2. Metcela

https://www.metcela.com/corporate/

· Year Founded: 2016

· Total Raised to Date: $20.9M

· Overview:

Metcela is a company that researches and develops ways to treat heart disease using fibroblasts.

3. JUNTEN BIO

https://juntenbio.co.jp/

· Year Founded: 2018

· Total Raised to Date: $29.4M

· Overview:

JUNTEN BIO is a company engaged in the research and development of cellular pharmaceuticals and regenerative medicine products, as well as pharmaceuticals and diagnostic reagents.

4. GAIA BioMedicine

https://gaia-biomed.com/

· Year Founded: 2015

· Total Raised to Date: $27.8M

· Overview:

JUNTEN BIO is a company engaged in the research and development of cellular pharmaceuticals and regenerative medicine products, as well as pharmaceuticals and diagnostic reagents.

5. CellAxia

https://www.cellaxia.co.jp/

· Year Founded: 2017

· Total Raised to Date: $14.0M

· Overview:

CellAxia is a company that aims to commercialize advanced research such as cell therapy.

6. AdipoSeeds

http://www.adiposeeds.co.jp/

· Year Founded: 2016

· Total Raised to Date: $4.5M

· Overview:

AdipoSeeds is a company that provides technology licenses to R&D and manufacturing partners for the practical application of regenerative medicine products using cells derived from adipose tissue.

7. Megakaryon

http://www.megakaryon.com/

· Year Founded: 2011

· Total Raised to Date: $102M

· Overview:

Megakaryon is a company that aims to clinically apply the technology to produce platelets from human iPS cells invented by Kyoto University and the University of Tokyo.

8. Heartseed

http://heartseed.jp/index.html

· Year Founded: 2015

· Total Raised to Date: $81.3M

· Overview:

Heartseed is a company that aims to treat patients with severe heart failure with regenerated heart muscle derived from iPS cells.

9. Cellusion

https://cellusion.jp/

· Year Founded: 2015

· Total Raised to Date: $17.0M

· Overview:

Cellusion is a company engaged in the research and development of corneal endothelial regenerative medicine using iPS cells.

10. Rege Nephro

https://www.regenephro.co.jp/

· Year Founded: 2019

· Total Raised to Date: $4.6M

· Overview:

Rege Nephro is a company engaged in the research, development, production and marketing of iPS cell-based therapeutics for renal diseases.

11. RAINBOW

https://rainbowinc.co.jp/about/

· Year Founded: 2019

· Total Raised to Date: $1.5M

· Overview:

RAINBOW is a company that conducts research and development of autologous bone marrow MSC products using its proprietary HUNS001 technology.